K213302: exoplan (FDA 510(k) & Recall Dossier)
U.S. FDA 510(k) Premarket Notification K213302 (exoplan, cleared 2022-05-03 for Exocad GmbH) reconciled with CDRH recall records on Predicate Ledger.
| Regulatory Field | Verified FDA Record |
|---|---|
| FDA 510(k) Number | K213302 |
| Cleared Device Trade / Generic Name | exoplan |
| FDA Applicant on Filing | Exocad GmbH |
| FDA 3-Letter Product Classification | Product Code LLZ |
| FDA Substantial Equivalence Decision Date | 2022-05-03 |
| De-Broadcasted Recall Linkage | Linked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026) |
Inspect consolidated manufacturer lineage at Exocad GmbH, compare peer devices under FDA Product Code LLZ, or browse all 20 FDA clinical specialties.
Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.